ADVERSE EVENTS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGIFN-ALFA AND RIBAVIRIN IN REAL-WORLD SETTING

被引：0
|
作者：
Shen, Sophie W. [1 ]
Dimitrova, Dessislava [1 ]
Hines, Patricia [2 ]
Gomez-Caminero, Andres [1 ]
机构：
[1] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA
[2] Bristol Myers Squibb, Ctr Observat Res & Data Sci, Hopewell, NJ USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：855A / 856A
页数：2
相关论文
共 50 条
  • [1] Risks of Adverse Events in Treated Chronic Hepatitis C Patients with Cirrhosis Compared to without Cirrhosis in Real-World Settings
    Shen, Sophie W.
    Ives, Jennifer Wood
    Hines, Patricia
    Dimitrova, Dessislava
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 65 - 66
  • [2] Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin
    Thevenot, T
    Mathurin, P
    Moussalli, J
    Perrin, M
    Plassart, F
    Blot, C
    Opolon, P
    Poynard, T
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 (04) : 243 - 253
  • [3] Plasma TIMP-1 concentration in patients with chronic hepatitis C treated with PegIFN and ribavirin
    Prztbyla, A.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 12 - 12
  • [4] Real-world efficacy of sofosbuvir and daclatasvir, with and without ribavirin for patients with chronic hepatitis C in Asia
    Chirapongsathorn, Sakkarin
    Wongpaitoon, Virasak
    Phanubol, Patamaporn
    Techapaitoon, Satien
    Sukhabote, Rujapong
    Osangthamnont, Charkaphan
    Anuras, Sinn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 163 - 163
  • [5] Anemia in patients with chronic hepatitis C treated with ribavirin and recombinant interferon alfa.
    Pablo, R
    Gomez, F
    Rosso, A
    Gonzalez, E
    Fernandez, J
    Viola, L
    Findor, JA
    Silva, M
    Favaloro, F
    Tanno, H
    Bruch, E
    Camps, D
    Pinchuk, L
    HEPATOLOGY, 1999, 30 (04) : 633A - 633A
  • [6] A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon
    Fattovich, G
    Giustina, G
    Favarato, S
    Ruol, A
    Macarri, G
    Orlandi, F
    Iaquinto, G
    Ambrosone, L
    Francavilla, A
    Pastore, G
    Santantonio, MT
    Romagno, D
    Bolondi, L
    Sofia, S
    Marchesini, A
    Pisi, E
    Mazzella, G
    Roda, E
    Attaro, L
    Chiodo, F
    Mori, F
    Verucchi, G
    Lanzini, A
    Salmi, A
    Calvi, B
    Bozzetti, F
    Radaeli, E
    Bernasconi, M
    Pilleri, G
    Bacca, D
    Romano, G
    Mastrapasqua, G
    Cozzolongo, R
    Cacopardo, B
    Nunnari, A
    Blasi, A
    Sala, LO
    Minoli, G
    Sangiovanni, A
    Spinzi, GC
    Colombo, A
    Camassa, M
    Riva, D
    Maggi, G
    Boccia, S
    Gualandi, G
    Nucci, A
    Pacini, F
    Marino, N
    Mazzotta, F
    JOURNAL OF HEPATOLOGY, 1996, 24 (01) : 38 - 47
  • [7] The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
    Walker, David R.
    Juday, Timothy R.
    Manthena, Shivaji R.
    Jing, Yonghua
    Sood, Vipan
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 637 - 642
  • [8] SUSTAINED VIROLOGIC RESPONSE (SVR) IN AMERICAN NAIVE MONO-INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS (PTS) TREATED WITH PEGINTERFERON ALFA (PEGIFNα) PLUS RIBAVIRIN (RBV): FINAL ANALYSIS OF THE LARGE, MULTINATIONAL REAL-WORLD PROPHESYS DATABASE
    Nelson, David R.
    Hassanein, Tarek
    Shiffman, Mitchell L.
    Rodriguez-Torres, Maribel
    Pruthi, Jatinder
    Tice, Alan D.
    Herring, Robert W.
    Beavers, Kimberly L.
    Schmitz, Manuela
    Hamzeh, Fayez
    HEPATOLOGY, 2011, 54 : 865A - 866A
  • [9] Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
    Matteo Megna
    Cataldo Patruno
    Maria Rita Bongiorno
    Alessio Gambardella
    Claudio Guarneri
    Paolo Romita
    Annunziata Raimondo
    Francesco Loconsole
    Gabriella Fabbrocini
    Clinical Drug Investigation, 2022, 42 : 525 - 531
  • [10] Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
    Megna, Matteo
    Patruno, Cataldo
    Bongiorno, Maria Rita
    Gambardella, Alessio
    Guarneri, Claudio
    Romita, Paolo
    Raimondo, Annunziata
    Loconsole, Francesco
    Fabbrocini, Gabriella
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 525 - 531
12345